Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2019 Apr 11;6(4):282-290.
doi: 10.1002/mdc3.12755. eCollection 2019 Apr.

Economic Evaluation of Interventions in Parkinson's Disease: A Systematic Literature Review

Nafsika Afentou  1   2 , Johan Jarl  1 , Ulf-G Gerdtham  1   3   4 , Sanjib Saha  1
Affiliations
Review

Economic Evaluation of Interventions in Parkinson's Disease: A Systematic Literature Review

Nafsika Afentou et al. Mov Disord Clin Pract. .

Abstract

Background: Parkinson's disease (PD) management comprises of drug treatments, surgery, and physical activity/occupational therapies to relieve PD's symptoms. The aim of this study is twofold; first, to appraise recent economic evaluation studies on PD management in order to update the existing knowledge; and second, to facilitate decision making on PD management by assessing the cost-effectiveness of all types of PD interventions.

Methods: A systematic search for studies published between 2010 and 2018 was conducted. The inclusion and exclusion of the articles were based on criteria relevant to population, intervention, comparison, outcomes, and study design (PICO). The reporting quality of the articles was assessed according to Consolidated Health Economic Evaluation Reporting Standards.

Results: Twenty-eight articles were included, 10 of which were evaluations of drug treatments, 10 deep brain stimulation (DBS), and eight physical/occupational therapies. Among early-stage treatments, Ti Ji dominated all physical activity interventions; however, its cost-effectiveness should be further explored in relation to its duration, intensity, and frequency. Multidisciplinary interventions of joint medical and nonmedical therapies provided slightly better health outcomes for the same costs. In advanced PD patients, adjunct drug treatments could become more cost-effective if introduced during early PD and, although DBS was more cost-effective than adjunct drug therapies, the results were time-bound.

Conclusions: Conditionally, certain PD interventions are cost-effective. However, PD progression differs in each patient; thus, the cost-effectiveness of individually tailored combinations of interventions that could provide more time in less severe disease states and improve patients' and caregivers' quality of life, should be further explored.

Keywords: Parkinson's disease; Parkinson's disease management; cost‐effectiveness; economic evaluations.

PubMed Disclaimer

Figures

Figure 1
Figure 1
PRISMA flow chart for the selection of studies
See this image and copyright information in PMC

References

    1. de Lau LML, Breteler MMB. Epidemiology of Parkinson's disease. The Lancet Neurol 2006;5(6):525–535. - PubMed
    1. Tinelli, Kanavos P, Grimaccia F. The value of early diagnosis and treatment in parkinson's disease: a literature review of the potential clinical and socioeconomic impact of targeting unmet needs in Parkinson's disease. London: The London School of Economics and Political Science; 2016.
    1. Kowal SL, Dall TM, Chakrabarti R, Storm MV, Jain A. The current and projected economic burden of Parkinson's disease in the United States. Mov Disord 2013;28(3):311–318. - PubMed
    1. Gustavsson A, Svensson M, Jacobi F, et al. Cost of disorders of the brain in Europe 2010. Eur Neuropsychopharmacol 2011;21:718–779. - PubMed
    1. Céu M, Coloma J. Health economics and cost of illness in Parkinson's disease. Mov Disord 2013;8(1):6–9.

LinkOut - more resources